Company intelligence / Profile preview
Enzychem Lifesciences
Seoul, Seoul, South Koreaenzychem.com ↗
- Ownership
- Private
- Employees
- ~122
- Development stage
- Other
01
Overview
Enzychem’s lead candidate EC‑18 has completed Phase II studies for chemoradiation-induced oral mucositis and has shown safety/tolerability. The company also has ongoing or planned trials in chemotherapy-induced neutropenia, acute radiation syndrome, COVID‑19–related ARDS, NASH, and immune checkpoint inhibitor-related toxicities. Fast Track Designation was granted by the US FDA for CRIOM; Orphan Drug Designation was granted for ARS. Preclinical data support anti-inflammatory effects across several disease models.[1][2][6]
- Therapeutic areas
- GastroenterologyImmunologyOncologyRare DiseasesInfectious Diseases
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
National Institutes of Health/NIAID CCRP collaboration on CERF program; potential BARDA funding for ARS program[6][7].
Beyond the preview
Go deeper on Enzychem Lifesciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enzychem Lifesciences.